척수질환의 척도
Scales for Spinal Cord Disorders
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Clinical scales are important tools for quantitatively evaluating impairments and disabilities related to diseases. Clinical scales are also used in many clinical studies to assess therapeutic effects. Spinal cord disorders cause neurological deterioration, which leads to functional and social disabilities. For many neurological disorders that cause myelopathy, including multiple sclerosis and other inflammatory demyelinating diseases, numerous drugs are being developed and studied for clinical use. Thus, clinical scales for myelopathy are important for both the medical field and general public. This review article describes the clinical scales for myelopathy, especially those that are widely used and established. We expect that this review will help readers choose the scales appropriate for their purposes.
Abstract
Clinical scales are important tools for quantitatively evaluating impairments and disabilities related to diseases. Clinical scales are also used in many clinical studies to assess therapeutic effects. Spinal cord disorders cause neurological deterioration, which leads to functional and social disabilities. For many neurological disorders that cause myelopathy, including multiple sclerosis and other inflammatory demyelinating diseases, numerous drugs are being developed and studied for clinical use. Thus, clinical scales for myelopathy are important for both the medical field and general public. This review article describes the clinical scales for myelopathy, especially those that are widely used and established. We expect that this review will help readers choose the scales appropriate for their purposes.
참고문헌 (26)
- Cho TA, "Approach to myelopathy", Continuum, 24, pp.386~406 (2018)
- Schuntermann MF, "The International classification of impairments, disabilities and handicaps (ICIDH) - results and problems", Int J Rehabil Res, 19, pp.1~11 (1996)
- American Spinal Injury Association, "Standards for neurological classification of spinal injury pa", American Spinal Injury Association, ~ (1984)
- Frankel HL, "The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I", Paraplegia, 7, pp.179~192 (1969)
- Kirshblum SC, "International standards for neurological classification of spinal cord injury (revised 2011)", J Spinal Cord Med, 34, pp.535~546 (2011)
- ASIA and ISCoS International Standards Committee, "The 2019 revision of the international standards for neurological classification of spinal cord injury (ISNCSCI)-What’s new?", Spinal Cord, 57, pp.815~817 (2019)
- Yonenobu K, "Causes of neurologic deterioration following surgical treatment of cervical myelopathy", Spine, 11, pp.818~823 (1986)
- Tetreault L, "The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy", Eur Spine J, 26, pp.78~84 (2017)
- Castilhos RM, "Severity score system for progressive myelopathy:development and validation of a new clinical scale", Braz J Med Biol Res, 45, pp.565~572 (2012)
- Nurick S, "The pathogenesis of the spinal cord disorder associated with cervical spondylosis", Brain, 95, pp.87~100 (1972)
- Revanappa, KK, "Comparison of Nurick grading system and modified Japanese Orthopaedic Association scoring system in evaluation of patients with cervical spondylotic myelopathy", Eur Spine J, 20, pp.1545~1551 (2011)
- Ashworth B, "Preliminary trial of carisoprodal in multiple sclerosis", Practitioner, 192, pp.540~542 (1964)
- Bohannon RW, "Inter-rater reliability of a modified Ashworth scale of muscle spasticity", Phys Ther, 67, pp.206~207 (1987)
- Ansari NN, "The interrater and intrarater reliability of the modified Ashworth scale in the assessment of muscle spasticity: limb and muscle group effect", NeuroRehabilitation, 23, pp.231~237 (2020)
- Pandyan AD, "A review of the properties and limitations of Ashworth and modified Ashworth scales as measures of spasticity", Clin Rehabil, 13, pp.373~383 (1999)
- Kurtzke JF, "The effects of isoniazid on patients with multiple sclerosis: preliminary report", Am Rev Tuberc, 70, pp.577~592 (1954)
- Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", Neurology, 33, pp.1444~1452 (1983)
- Wilson JL, "Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview", Stroke, 36, pp.777~781 (2005)
- Rankin J, "Cerebral vascular accidents in patients over the age of 60. II. Prognosis", Scott Med J, 2, pp.200~215 (1957)
- van Swieten JC, "Interobserver agreement for the assessment of handicap in stroke patients", Stroke, 19, pp.604~607 (1988)
- Patel N, "Simple and reliable determination of the modified Rankin Scale in neurosurgical and neurological patients: the mRS-9Q", Neurosurgery, 71, pp.971~975 (2012)
- Shah S, "Improving the sensitivity of the Barthel index for stroke rehabilitation", J Clin Epidemiol, 42, pp.703~709 (1989)
- Maboney F, "Functional evaluation: the Barthel index", Md State Med J, 14, pp.61~65 (1965)
- 정한영, "한글판 수정바델지수(K-MBI)의 개발: 뇌졸중 환자 대상의 다기관 연구", Annals of Rehabilitation Medicine, 31(3), pp.283~297 (2007), 대한재활의학회
- Sellner J, "Diagnostic workup of patients with acute transverse myelitis:spectrum of clinical presentation, neuroimaging and laboratory findings", Spinal Cord, 47, pp.312~317 (2009)
- Benzel EC, "Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy", J Spinal Disord, 4, pp.286~295 (1991)